Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Viatris (VTRS)
NASDAQ:VTRS
VTRS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$9.93 - $13.62
Previous CloseN/A
Volume2.11M
Average Volume (3M)9.65M
Market Cap
$12.89B
Enterprise Value$27.98B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Feb 27, 2025EPS Estimate
0.57Last Dividend Ex-Date
Nov 22, 2024Dividend Yield4.42%
Share Statistics
EPS (TTM)-0.74
Shares Outstanding1,193,592,900
10 Day Avg. Volume8,262,690
30 Day Avg. Volume9,649,657
Standard Deviation0.10
R-Squared0.26
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.86
Price to Cash Flow (P/CF)3.90
P/FCF Ratio3.60
Enterprise Value/Market Cap2.17
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.35
Enterprise Value/Ebitda11.13
Forecast
1Y Price Target
$14.50Price Target Upside32.66% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
---
Viatris News
PremiumCompany Announcements
Viatris Elects Directors and Amends Stock Plan at Meeting
PremiumCompany Announcements
Viatris Inc. Reports Strong Q3 2024 Performance
---
Bulls Say, Bears Say
Bulls Say
Earnings GuidanceViatris is expected to benefit from a strong guide into 2025, which could act as a catalyst for its shares.
Product PipelineThe company expects significant new product revenues, supported by an estimated 140 filings annually, which contribute to incremental growth.
Share BuybacksViatris plans to be more aggressive with buybacks, supported by its financial flexibility and a substantial amount of free cash flow.
Bears Say
Growth ProspectsViatris has limited potential for upward revisions and lacks clinical catalysts for 2025, which affects its growth prospects.
Market PerformanceAnalyst reiterates an Underperform rating for Viatris, suggesting the shares are likely to lag peers and the broader market.
Sales And EBITDA DeclineThe company faces sequential headwinds in the fourth quarter, with expected declines in sales and EBITDA.
---
Ownership Overview
0.16% Insiders
23.34% Mutual Funds
20.99% Other Institutional Investors
25.94% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VTRS FAQ
What was Viatris’s price range in the past 12 months?
Viatris lowest stock price was $9.93 and its highest was $13.62 in the past 12 months.
What is Viatris’s market cap?
Viatris’s market cap is $12.89B.
When is Viatris’s upcoming earnings report date?
Viatris’s upcoming earnings report date is Feb 27, 2025 which is in 7 days.
How were Viatris’s earnings last quarter?
Viatris released its earnings results on Nov 07, 2024. The company reported $0.75 earnings per share for the quarter, beating the consensus estimate of $0.677 by $0.073.
Is Viatris overvalued?
According to Wall Street analysts Viatris’s price is currently Undervalued.
Does Viatris pay dividends?
Viatris pays a Quarterly dividend of $0.119 which represents an annual dividend yield of 4.42%. See more information on Viatris dividends here
What is Viatris’s EPS estimate?
Viatris’s EPS estimate is 0.57.
How many shares outstanding does Viatris have?
Viatris has 1,193,592,900 shares outstanding.
What happened to Viatris’s price movement after its last earnings report?
Viatris reported an EPS of $0.75 in its last earnings report, beating expectations of $0.677. Following the earnings report the stock price went up 13.565%.
Which hedge fund is a major shareholder of Viatris?
Currently, no hedge funds are holding shares in VTRS
---
Viatris Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.50 (32.66% Upside)
$14.50 (32.66% Upside)
Blogger Sentiment
Bullish
VTRS Sentiment 88%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 48.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $346.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 0.2%
Last 30 Days ▲ 0.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.42%
12-Months-Change
Fundamentals
Return on Equity
-4.35%
Trailing 12-Months
Asset Growth
-8.18%
Trailing 12-Months
Company Description
Viatris
Viatris Inc. is a global healthcare company headquartered in Canonsburg, Pennsylvania. Formed in 2020 through the merger of Mylan and Pfizer’s Upjohn division, Viatris provides a wide range of medicines, including branded drugs, generics, biosimilars, and over-the-counter products. The company operates in over 165 countries and serves patients across numerous therapeutic areas, including infectious diseases, cardiovascular health, and oncology. Viatris also offers patient support programs and works with healthcare systems to address medical needs worldwide.
---
VTRS Company Deck
---
VTRS Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong financial performance with consistent operational revenue growth and strategic debt reduction. The company is focused on expanding its innovative portfolio, particularly in cardiovascular and ophthalmology sectors. While there are challenges related to the ARV generics supply chain and certain brand declines, the overall outlook remains positive with plans for shareholder value maximization and disciplined business development.Read More>---
VTRS Net sales Breakdown
60.12% Developed Markets
16.58% Emerging Markets
14.04% Greater China
9.26% JANZ
---
VTRS Stock 12 Month Forecast
Average Price Target
$14.50
▲(32.66% Upside)
Technical Analysis
Best Analysts Covering VTRS
1 Year
1 Year Success Rate
8/19 ratings generated profit
1 Year Average Return
-6.84%
reiterated a sell rating 3 months ago
Copying Balaji Prasad's trades and holding each position for 1 Year would result in 42.11% of your transactions generating a profit, with an average return of -6.84% per trade.
---